Show simple item record

Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer

dc.contributor.authorKarabulut, S.
dc.contributor.authorTas, Faruk
dc.contributor.authorSen, F.
dc.contributor.authorCiftci, R.
dc.date.accessioned2021-03-03T20:47:44Z
dc.date.available2021-03-03T20:47:44Z
dc.identifier.citationKarabulut S., Ciftci R., Sen F., Tas F., "Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer", European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49
dc.identifier.othervv_1032021
dc.identifier.otherav_5bd880ba-9b58-4df3-b2b2-2eeab1e4b9ac
dc.identifier.urihttp://hdl.handle.net/20.500.12627/64426
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleClinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume49
dc.contributor.firstauthorID38260


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record